HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R M Refini Selected Research

Biological Therapy

4/2020Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R M Refini Research Topics

Disease

2Asthma (Bronchial Asthma)
04/2020 - 09/2019
2Sarcoidosis (Schaumann Disease)
10/2015 - 09/2008
2Idiopathic Pulmonary Fibrosis
06/2014 - 02/2014
2Interstitial Lung Diseases (Interstitial Lung Disease)
06/2014 - 02/2014
1COVID-19
01/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
09/2019
1Tuberculosis (Tuberculoses)
10/2015
1Inflammation (Inflammations)
10/2015
1Chronic Obstructive Pulmonary Disease (COPD)
10/2015
1Pneumonia (Pneumonitis)
09/2015
1Infections
09/2015
1Lung Injury
06/2014
1Fibrosis (Cirrhosis)
06/2014
1Idiopathic Interstitial Pneumonias
06/2014

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
10/2015 - 06/2014
2Carbon MonoxideIBA
09/2015 - 09/2008
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2015 - 06/2014
1SteroidsIBA
01/2021
1Environmental BiomarkersIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Monoclonal AntibodiesIBA
04/2020
1anti-IgE antibodiesIBA
09/2019
1Omalizumab (Xolair)FDA Link
09/2019
1Albuterol (Salbutamol)FDA LinkGeneric
09/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2019
1Proteins (Proteins, Gene)FDA Link
10/2015
1Complement System Proteins (Complement)IBA
10/2015
1Blood Coagulation Factors (Coagulation Factor)IBA
02/2014

Therapy/Procedure

2Therapeutics
04/2020 - 09/2019
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Biological Therapy
04/2020